Close
0
Inquiry Basket

There is no product in the shopping cart, buy it!

Hot Products
Monosaccharide Products
Oligosaccharide Products
Polysaccharide Products
Carbohydrate-based Surfactant Products
Blood Group Antigen Products
Glycoprotein Products
Glycopeptide Products
Nucleotide Sugar Products
Glycoprotein Assay Kits
Comprehensive Glycoprotein Reagents
Glycoengineered Cell Products
Glycoengineering Viral Particle Products
Glycolipid Products

Recombinant Human BGN Protein, Fuco-Adjusted Human Cell Lines

CAT#: GLJF-0622-JF576

Datasheet Request COA
Specifications Target Information Related Products
Specifications
Product Overview
Recombinant human BGN protein (NP_001702.1) is produced in Fuco-Adjusted Human Cell Lines. This expression system is used for the production of glycoproteins and antibodies with different fucosylation degree.
Source
Fuco-Adjusted Human Cell Lines
Species
Human
Tag
His-tag, FC-tag
Purity
>90%, determined by SDS-PAGE.
Endotoxin Level
Regular batch
Conjugation
None
Target Information
Target
BGN
Full Name
Biglycan
Gene ID
633
Uniprot ID
P21810
Accession Number
NP_001702.1
Background
This gene encodes a member of the small leucine-rich proteoglycan (SLRP) family of proteins. The encoded preproprotein is proteolytically processed to generate the mature protein, which plays a role in bone growth, muscle development and regeneration, and collagen fibril assembly in multiple tissues. This protein may also regulate inflammation and innate immunity. Additionally, the encoded protein may contribute to atherosclerosis and aortic valve stenosis in human patients. This gene and the related gene decorin are thought to be the result of a gene duplication.
Alternate Names
Bone/cartilage proteoglycan I; PG-S1; BGN; SLRR1A
For Research Use Only.
Online Inquiry
Copyright © Creative Biolabs. All Rights Reserved.